| 期 |
栏目 |
标题 |
文件 |
| 卷 82, 编号 11 (2010) |
Editorial |
Outcomes of severe pandemic influenza A/H1N1/2009 |
|
| 卷 83, 编号 3 (2011) |
Editorial |
Determination of clinical phenotypes of chronic obstructive pulmonary disease a new treatment approach |
|
| 卷 84, 编号 3 (2012) |
Editorial |
SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS |
|
| 卷 84, 编号 3 (2012) |
Editorial |
ORGANIZING PNEUMONIA: DIAGNOSIS AND TREATMENT |
|
| 卷 84, 编号 3 (2012) |
Editorial |
THE ROLE OF ENDOTHELIAL DYSFUNCTION AND ARTERIAL RIGIDITY IN PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
|
| 卷 84, 编号 4 (2012) |
Editorial |
CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |
|
| 卷 90, 编号 3 (2018) |
Editorial |
Combination therapy is a new standard for treatment of pulmonary arterial hypertension |
(Rus)
|
| 卷 90, 编号 12 (2018) |
Editorial |
Treatment of exacerbations of chronic obstructive pulmonary disease |
(Rus)
|
| 卷 91, 编号 3 (2019) |
Editorial |
New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease |
(Rus)
|
| 卷 91, 编号 3 (2019) |
Editorial |
Possibilities of ultrasound research of the diaphragm |
(Rus)
|
| 卷 91, 编号 9 (2019) |
Editorial |
Risk stratification methods and their significance in pulmonary arterial hypertension |
(Rus)
|
| 卷 91, 编号 10 (2019) |
Editorial |
Eosinophilic inflammation in chronic obstructive pulmonary disease |
(Rus)
|
| 卷 92, 编号 1 (2020) |
Editorial |
The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy |
(Rus)
|
| 卷 92, 编号 3 (2020) |
Editorial |
Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity |
(Rus)
|
| 卷 92, 编号 3 (2020) |
Consensuns |
Exacerbation of idiopathic pulmonary fibrosis |
(Rus)
|
| 卷 92, 编号 2 (2020) |
Original articles |
Severe bronchial asthma patient care organization in various regions of the Russian Federation. From endotypes and phenotypes of bronchial asthma to personalized choice of therapy |
(Rus)
|
| 卷 92, 编号 4 (2020) |
Original articles |
Clinical efficacy of mechanical bacterial lysate in the prevention of infectious exacerbations of chronic obstructive pulmonary disease |
(Rus)
|
| 卷 92, 编号 11 (2020) |
Original articles |
Risk factors for the early development of septic shock in patients with severe COVID-19 |
(Rus)
|
| 卷 92, 编号 12 (2020) |
Articles |
Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma |
(Rus)
|
| 卷 95, 编号 3 (2023) |
Original articles |
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease |
(Rus)
|
| 卷 93, 编号 4 (2021) |
Original articles |
Peculiarities of Mild Asthma in Russia: the Results of SYGMA2 Study |
(Rus)
|
| 卷 95, 编号 1 (2023) |
Original articles |
Risk factors for adverse outcomes in elderly patients with asthma and severe COVID-19 at the hospital and early post-hospital stages |
(Rus)
|
| 卷 94, 编号 4 (2022) |
Original articles |
Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board |
(Rus)
|
| 卷 96, 编号 3 (2024) |
Original articles |
The role of spectral analysis of cough sounds in the diagnosis of COVID-19 |
(Rus)
|
| 卷 95, 编号 8 (2023) |
Consensuns |
The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic |
(Rus)
|
| 卷 95, 编号 11 (2023) |
Original articles |
The possibilities of impulse oscillometry in the diagnosis of the lung function disorders after COVID-19 |
(Rus)
|
| 卷 96, 编号 4 (2024) |
Original articles |
Efficacy and safety of levosalbutamol in patients with mild to moderate asthma compared with racemic salbutamol: results of a crossover placebo-controlled study |
(Rus)
|
| 卷 96, 编号 3 (2024) |
Reviews |
New clinical guidelines for COPD – a paradigm shift: A review |
(Rus)
|
